Skip to content

Clinical trials

Phase 1/2 Carcinoma, Renal Cell trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1/2 Country / region: South Korea Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20162
20181
20191
20202
20214
20231
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed6
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GI Innovation, Inc.3
Merck Sharp & Dohme LLC3
AstraZeneca1
Bristol-Myers Squibb1
Eutilex1
GeneMedicine Co., Ltd.1
Inhibrx Biosciences, Inc1
Medicenna Therapeutics, Inc.1
Mural Oncology, Inc1
NGM Biopharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell18
Melanoma8
Carcinoma, Non-Small-Cell Lung7
Squamous Cell Carcinoma of Head and Neck6
Colorectal Neoplasms4
Neoplasm Metastasis4
Stomach Neoplasms4
Uterine Cervical Neoplasms4
Neoplasms3
Breast Neoplasms2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.